SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-94-000125
Filing Date
1994-06-02
Accepted
1994-06-02 00:00:00
Documents
7
Group Members
BB BIOTECH AGBIOTECH FOCUS S.A.BIOTECH INVEST S.A.BIOTECH TARGET S.A.

Document Format Files

Seq Description Document Type Size
1 BIOGEN, INC. SC 13D SC 13D 33449
2 TRANSACTION SUMMARY EX-99.A 7054
3 POWER OF ATTORNEY EX-99.B 2333
4 POWER OF ATTORNEY EX-99.C 2329
5 POWER OF ATTORNEY EX-99.D 4275
6 POWER OF ATTORNEY EX-99.E 1776
7 JOINT FILING AGREEMENT EX-99.F 2143
  Complete submission text file 0000950133-94-000125.txt   56004
Mailing Address 00000
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 6172529200
BIOGEN INC (Subject) CIK: 0000714655 (see all company filings)

IRS No.: 043002117 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-35348 | Film No.: 94532754
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE, NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000